Image Box PR wins brief with UK biotechnology firm BioSilta

Image Box PR has been handed a new contract by BioSilta, a UK biotechnology company with subsidiaries in Germany and Finland.

The Surrey-based agency has been hired to help the client promote its range of innovative, reagent-based bacterial and yeast expression culture systems. It is the latest in a series of recent account wins for the firm, reports PMLiVE.

Image Box PR was also recently handed a brief by the International Society of Cellular Therapy, the global society dedicated to the translation of cellular therapy to the market, as well as Cell and Gene Therapy Catapult, a UK organisation working to drive growth in the UK cell and gene therapy industry.

The agency's work with Promethera Biosciences also positions it ideally to offer insights to BioSilta, which is best known for its proprietary EnBase technology platform, used to develop innovative reagent-based EnPresso growth systems.

Founded in 2007, BioSilta continues to grow, having agreed a deal to purchase exclusive global rights to CyDisCo protein production technology from the University of Oulu earlier this month.